| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 4 | +148K | 88.1% | $3.17 | +$469K |
| Sells | 2 | -20.1K | 11.9% | $4.98 | -$100K |
| Net | +2 | +128K | 76.1% | +$369K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Claude Maraoui | President & CEO, Director | $18.8M | +$34.8K | +0.19% | Mar 22, 2024 |
| Fortress Biotech, Inc. | 10%+ Owner | $11.7M | May 12, 2022 | ||
| Lindsay A. Md Rosenwald | Director | $2.52M | +$98.4K | +4.06% | Jul 8, 2024 |
| Ernest Robert De Paolantonio | Officer | $1.36M | Oct 4, 2022 | ||
| Justin Adam Smith | Director | $986K | +$202K | +25.8% | Jul 8, 2024 |
| Miranda Jayne Toledano | Director | $622K | Jul 8, 2024 | ||
| Neil Herskowitz | Director | $622K | Jul 8, 2024 | ||
| Jeffrey Paley | Director | $369K | +$116K | +45.8% | Nov 28, 2023 |
| Joseph Benesch | Cfo | $259K | -$82.1K | -24.1% | Aug 1, 2024 |
| Michael Cooper Pearce | Director | $162K | Jul 19, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|